About
Kodiak Sciences develops and commercializes biologic therapies targeting retinal diseases such as wet age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and macular edema secondary to inflammation.
Explore Kodiak Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.